Zeiss's Surgical Ophthalmology unit grows fastest in first quarter
Click Here to Manage Email Alerts
Carl Zeiss Meditec’s Surgical Ophthalmology unit led the company’s three strategic business units in first quarter growth rate, according to a company press release.
Overall, the company increased its revenue 13.6% to €241.1 million, with the Surgical Ophthalmology strategic business unit gaining a 22.4% increase to €81.6 million, up from €66.7 million in the same quarter last year.
The Microsurgery strategic business unit increased its revenue by 4.6% to €67.8 million, and the Ophthalmic Systems strategic business unit totaled €91.7 million for a 13.5% increase.
Earnings before interest and taxes totaled €27.9 million in the first quarter, despite an increase in costs for its strategic research project in ophthalmology.
Consolidated net income decreased 9.4% to €19.4 million, compared with €21.4 million in the first quarter of 2014.